These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21352638)

  • 1. Is there a role for aerosol nasal sprays in the treatment of allergic rhinitis: a white paper.
    Luskin AT; Blaiss MS; Farrar JR; Settipane R; Hayden ML; Stoloff S; Chadwick SJ; Derebery MJ; Ettari MP; Luskin S; Naclerio R
    Allergy Asthma Proc; 2011; 32(2):168-77. PubMed ID: 21352638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New therapeutic options for allergic rhinitis: back to the future with intranasal corticosteroid aerosols.
    Carr WW
    Am J Rhinol Allergy; 2013; 27(4):309-13. PubMed ID: 23816748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis.
    Bachert C; El-Akkad T
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):292-7. PubMed ID: 12269650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost efficiency of intranasal corticosteroid prescribing patterns in the management of allergic rhinitis.
    Reissman D; Price T; Leibman CW
    J Manag Care Pharm; 2004 Jan; 10(1 Suppl):S9-13. PubMed ID: 14720101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of mometasone furoate nasal spray on individual ocular symptoms of allergic rhinitis: a meta-analysis.
    Bielory L; Chun Y; Bielory BP; Canonica GW
    Allergy; 2011 May; 66(5):686-93. PubMed ID: 21261661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with seasonal allergic rhinitis.
    van Bavel JH; Ratner PH; Amar NJ; Hampel FC; Melchior A; Dunbar SA; Dorinsky PM; Tantry SK
    Allergy Asthma Proc; 2012; 33(5):386-96. PubMed ID: 23026180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class.
    Benninger M; Farrar JR; Blaiss M; Chipps B; Ferguson B; Krouse J; Marple B; Storms W; Kaliner M
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):13-29. PubMed ID: 20143641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of beclomethasone dipropionate nasal aerosol in pediatric patients with seasonal allergic rhinitis.
    Storms WW; Segall N; Mansfield LE; Amar NJ; Kelley L; Ding Y; Tantry SK
    Ann Allergy Asthma Immunol; 2013 Nov; 111(5):408-414.e1. PubMed ID: 24125150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of a novel nasal steroid, S0597, in patients with seasonal allergic rhinitis.
    Badorrek P; Hohlfeld JM; Krug N; Joshi A; Raut A
    Ann Allergy Asthma Immunol; 2015 Oct; 115(4):325-329.e1. PubMed ID: 26272281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory procedures. Part 6--Use of nasal sprays in allergic rhinitis.
    Burns D
    Nurs Times; 2007 Sep 11-17; 103(37):24-5. PubMed ID: 17902591
    [No Abstract]   [Full Text] [Related]  

  • 11. Azelastine and olopatadine in the treatment of allergic rhinitis.
    Kaliner MA
    Ann Allergy Asthma Immunol; 2009 Nov; 103(5):373-80. PubMed ID: 19927534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In brief: two intranasal corticosteroid HFA aerosols for allergic rhinitis.
    Med Lett Drugs Ther; 2012 Oct; 54(1401):84. PubMed ID: 23120798
    [No Abstract]   [Full Text] [Related]  

  • 13. Insights on allergic rhinitis from the patient perspective.
    Fromer LM; Ortiz G; Ryan SF; Stoloff SW
    J Fam Pract; 2012 Feb; 61(2 Suppl):S16-22. PubMed ID: 22312620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No hypothalamic-pituitary-adrenal function effect with beclomethasone dipropionate nasal aerosol, based on 24-hour serum cortisol in pediatric allergic rhinitis.
    Hampel FC; Nayak NA; Segall N; Small CJ; Li J; Tantry SK
    Ann Allergy Asthma Immunol; 2015 Aug; 115(2):137-42. PubMed ID: 26250771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluticasone furoate: a new intranasal corticosteroid.
    Kumar R; Kumar D; Parakh A
    J Postgrad Med; 2012; 58(1):79-83. PubMed ID: 22387656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caring for patients with allergic rhinitis.
    Hayden ML; Womack CR
    J Am Acad Nurse Pract; 2007 Jun; 19(6):290-8. PubMed ID: 17535338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of intranasal corticosteroid formulations for the treatment of allergic rhinitis.
    Wingertzahn MA; Derebery MJ; Nelson HS
    Allergy Asthma Proc; 2007; 28 Suppl 1():S18-24. PubMed ID: 18307840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of beclomethasone dipropionate nasal aerosol in children with perennial allergic rhinitis.
    Berger WE; Jacobs RL; Amar NJ; Tantry SK; Li J; Small CJ
    Ann Allergy Asthma Immunol; 2015 Aug; 115(2):130-6. PubMed ID: 26115578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal corticosteroids topical characteristics: side effects, formulation, and volume.
    Petty DA; Blaiss MS
    Am J Rhinol Allergy; 2013; 27(6):510-3. PubMed ID: 24274228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis.
    Mahadevia PJ; Shah S; Leibman C; Kleinman L; O'Dowd L
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):345-50. PubMed ID: 15521370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.